The Value Line Investment Survey (Part 3 - Ratings & Reports) 2004 Keith A. Markey - Abstracts
| The Value Line Investment Survey (Part 3 - Ratings & Reports) 2004 Keith A. Markey | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Advanced Neuromodulation. | Business, general | Keith A. Markey | |||
| Allergan, Inc. | Business, general | Keith A. Markey | |||
| Allergan, Inc.. | Business, general | Keith A. Markey | |||
| Baxter International. | Business, general | Keith A. Markey | |||
| Biotechnology industry.(securities analysis as of December 24, 2004)(Industry Overview) | Business, general | George Rho, Charles Clark, Keith A. Markey, J. Susan Ferrara, Andre J. Costanza, William C. Lewittes | |||
| Biotechnology industry.(securities analysis as of June 25, 2004)(Industry Overview) | Business, general | George Rho, Charles Clark, Keith A. Markey, J. Susan Ferrara, Andre J. Costanza, William C. Lewittes | |||
| Biotechnology industry.(securities analysis as of September 24, 2004)(Industry Overview) | Business, general | George Rho, Charles Clark, Keith A. Markey, J. Susan Ferrara, Andre J. Costanza, William C. Lewittes | |||
| Celgene Corp. | Business, general | Keith A. Markey | |||
| Charles River laboratories Int'l. | Business, general | Keith A. Markey | |||
| CryoLife Inc. | Business, general | Keith A. Markey | |||
| CryoLife, Inc. | Business, general | Keith A. Markey | |||
| Cyberonics, Inc. | Business, general | Keith A. Markey | |||
| Cyberonics, Inc. | Business, general | Keith A. Markey | |||
| Diversified company industry.(industry securities and financial analysis) | Business, general | John Marrin, Justin T. Sebastiano, Perry H. Roth, Theresa Brophy, Keith A. Markey, Morton L. Siegel, Erik M. Manning, Randy Shrikishun, Joseph A. Beyrouty, James M. Herth, Andre J. Constanza, Robert E. Du Boff, W. R. Pekowitz, C. F. KUboyama | |||
| Drug industry.(industry securities and financial analysis) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Charles L. Stone, William C. Lewittes | |||
| Drug industry.(securities analysis as of October 22, 2004)(Industry Overview) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes | |||
| Enzo Biochem. | Business, general | Keith A. Markey | |||
| Genentech, Inc. | Business, general | Keith A. Markey | |||
| Haemonetics Corp. | Business, general | Keith A. Markey | |||
| HCA Inc. | Business, general | Keith A. Markey | |||
| Invitrogen Corp. | Business, general | Keith A. Markey | |||
| Medarex Inc. | Business, general | Keith A. Markey | |||
| Medical services industry.(securities analysis as of December 24, 2004)(Industry Overview) | Business, general | George Rho, Mario Ferro, Keith A. Markey, J. Susan Ferrara, Erik M. Manning, Randy Shrikishun, William C. Lewittes | |||
| Medical services industry.(securities analysis as of June 25, 2004)(Industry Overview) | Business, general | George Rho, Mario Ferro, Keith A. Markey, J. Susan Ferrara, Erik M. Manning, Randy Shrikishun, Robert E. Du Boff, William C. Lewittes | |||
| Medical services industry.(securities analysis as of September 24, 2004)(Industry Overview) | Business, general | George Rho, Mario Ferro, Keith A. Markey, J. Susan Ferrara, Erik M. Manning, Randy Shrikishun, William C. Lewittes | |||
| Medical supplies industry.(securities analysis as of December 3, 2004)(Industry Overview) | Business, general | Kenneth A. Nugent, George Rho, Lucien Virgile, Dylan D. Cathers, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, William C. Lewittes, Erik Antonson, Alex Roomets | |||
| Medical supplies industry.(securities analysis as of September 3, 2004)(Industry Overview) | Business, general | Kenneth A. Nugent, George Rho, Lucien Virgile, Dylan D. Cathers, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, William C. Lewittes, Fritz R. Owens, Erik Antonson | |||
| Medimmune Inc. | Business, general | Keith A. Markey | |||
| Molecular Devices. | Business, general | Keith A. Markey | |||
| Myriad Genetics. | Business, general | Keith A. Markey | |||
| Neose Tech., Inc. | Business, general | Keith A. Markey | |||
| Neurocrine Biosciences. | Business, general | Keith A. Markey | |||
| Parexel Intl. Corp. | Business, general | Keith A. Markey | |||
| Perrigo Co. | Business, general | Keith A. Markey | |||
| Pharmacopeia, Inc. | Business, general | Keith A. Markey | |||
| Semiconductor (capital equipment).(securities analysis as of October 15, 2004)(Industry Overview) | Business, general | John Koller, Noah Goldner, Lucien Virgile, Warren Thorpe, Theresa Brophy, Rick S. Plummer, Edward Plank, Keith A. Markey, Charles W. Noh, Daniel K. Cooney, Garrett Sussman | |||
| Thoratec Corp. | Business, general | Keith A. Markey | |||
| Visx, Inc. | Business, general | Keith A. Markey | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.